ES2157539T3 - Derivados del benzopirano, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. - Google Patents
Derivados del benzopirano, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.Info
- Publication number
- ES2157539T3 ES2157539T3 ES97402821T ES97402821T ES2157539T3 ES 2157539 T3 ES2157539 T3 ES 2157539T3 ES 97402821 T ES97402821 T ES 97402821T ES 97402821 T ES97402821 T ES 97402821T ES 2157539 T3 ES2157539 T3 ES 2157539T3
- Authority
- ES
- Spain
- Prior art keywords
- sub
- group
- benzopirane
- derivatives
- pharmaceutical compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- YZCKVEUIGOORGS-UHFFFAOYSA-N Hydrogen atom Chemical compound [H] YZCKVEUIGOORGS-UHFFFAOYSA-N 0.000 abstract 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/66—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
- C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
LA INVENCION ESTA RELACIONADA CON LOS COMPUESTOS QUE RESPONDEN A LA FORMULA GENERAL (I): DONDE: R SUB,1} REPRESENTA UN GRUPO ALQUIL; R SUB,2}, R SUB,4} Y R SUB,5}, IDENTICOS O DIFERENTES, REPRESENTAN UN ATOMO DE HIDROGENO O UN GRUPO ALQUIL; R SUB,3} REPRESENTA UNO CUALQUIERA DE LOS GRUPOS DEFINIDOS EN LA DESCRIPCION; X REPRESENTA UN GRUPO CARBONIL O UN GRUPO METILENO; Y REPRESENTA UN ATOMO DE HIDROGENO O UN GRUPO ALQUIL O ARIL; A REPRESENTA UN ENLACE SIMPLE O UN GRUPO ALQUILFENIL; R SUB,6} REPRESENTA UNO CUALQUIERA DE LOS GRUPOS DEFINIDOS EN LA DESCRIPCION, SUS ISOMEROS Y TAMBIEN SUS SALES DE ADICION A UN ACIDO O UNA BASE FARMACEUTICAMENTE ACEPTABLE. DE APLICACION EN LA FABRICACION DE MEDICAMENTOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9614470A FR2756284B1 (fr) | 1996-11-26 | 1996-11-26 | Nouveaux derives du benzopyrane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2157539T3 true ES2157539T3 (es) | 2001-08-16 |
Family
ID=9498038
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES97402821T Expired - Lifetime ES2157539T3 (es) | 1996-11-26 | 1997-11-24 | Derivados del benzopirano, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. |
Country Status (19)
Country | Link |
---|---|
US (1) | US5889045A (es) |
EP (1) | EP0844245B1 (es) |
JP (1) | JPH10158260A (es) |
CN (1) | CN1183412A (es) |
AT (1) | ATE201020T1 (es) |
AU (1) | AU720479B2 (es) |
BR (1) | BR9705064A (es) |
CA (1) | CA2222467C (es) |
DE (1) | DE69704755T2 (es) |
DK (1) | DK0844245T3 (es) |
ES (1) | ES2157539T3 (es) |
FR (1) | FR2756284B1 (es) |
GR (1) | GR3036242T3 (es) |
HU (1) | HUP9702227A3 (es) |
NO (1) | NO975402L (es) |
NZ (1) | NZ329264A (es) |
PL (1) | PL323339A1 (es) |
PT (1) | PT844245E (es) |
ZA (1) | ZA9710649B (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1268942A (zh) | 1997-06-27 | 2000-10-04 | 藤泽药品工业株式会社 | 磺酰胺化合物及其药物用途 |
AU2440599A (en) * | 1998-02-25 | 1999-09-15 | Shionogi & Co., Ltd. | Therapeutic agent for complication of diabetes |
KR100352986B1 (ko) * | 2000-04-28 | 2002-09-18 | 주식회사 태평양 | 세라미드 유사 화합물 및 이의 제조방법, 및 이를함유하는 화장료 조성물 |
JP2006514666A (ja) * | 2003-02-26 | 2006-05-11 | 中国科学院上海薬物研究所 | ベンゾピラン系化合物、その製造方法及び用途 |
WO2007035640A2 (en) * | 2005-09-16 | 2007-03-29 | Cornell Research Foundation, Inc. | Methods for reducing cd36 expression |
EP3456707B1 (en) * | 2007-11-06 | 2020-04-15 | PTC Therapeutics, Inc. | 4- (p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases |
WO2016188766A1 (en) | 2015-05-22 | 2016-12-01 | Sulfateq B.V. | Compound for the prophylaxis or treatment of organ damage |
TW201831471A (zh) * | 2017-02-24 | 2018-09-01 | 盧森堡商艾伯維公司 | 囊腫纖化症跨膜傳導調節蛋白的調節劑及其使用方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUT64318A (en) * | 1990-07-25 | 1993-12-28 | Teijin Ltd | Process for production benzodpyrane derivativs and pharmaceutical preparations containing these compounds as effective substance |
FR2676056B1 (fr) * | 1991-05-03 | 1993-07-16 | Adir | Nouveaux derives du benzopyranne leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
KR950009863B1 (ko) * | 1991-05-22 | 1995-08-29 | 재단법인한국화학연구소 | 벤조피란 유도체와 그의 제조방법 |
TW244350B (es) * | 1991-12-14 | 1995-04-01 | Hoechst Ag | |
ZA93436B (en) * | 1992-01-24 | 1993-08-25 | Chugai Pharmaceutical Co Ltd | Benzopyran derivatives |
US5236935A (en) * | 1992-05-21 | 1993-08-17 | Korea Research Institute Of Chemical Technology | Benzopyran derivatives and processes for the preparation thereof |
US5516917A (en) * | 1994-06-08 | 1996-05-14 | G. D. Searle & Co. | Leukotriene B4 antagonists |
DE69524528T2 (de) * | 1994-10-14 | 2002-08-01 | Merck Patent Gmbh | ZNS wirksames (R)-(-)-2-[5-(4-Fluorophenyl)-3-pyridylmethylaminomethyl]chroman |
FR2733685B1 (fr) * | 1995-05-05 | 1997-05-30 | Adir | Utilisation des derives du benzopyrane pour l'obtention de compositions pharmaceutiques destinees au traitement des pathologies liees a l'echangeur c1-/hc03-, na+ independant |
DE19546736A1 (de) * | 1995-12-14 | 1997-06-19 | Hoechst Ag | Substituierte Chromanylsulfonyl(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Präparate |
-
1996
- 1996-11-26 FR FR9614470A patent/FR2756284B1/fr not_active Expired - Fee Related
-
1997
- 1997-11-24 AT AT97402821T patent/ATE201020T1/de not_active IP Right Cessation
- 1997-11-24 EP EP97402821A patent/EP0844245B1/fr not_active Expired - Lifetime
- 1997-11-24 PT PT97402821T patent/PT844245E/pt unknown
- 1997-11-24 DK DK97402821T patent/DK0844245T3/da active
- 1997-11-24 ES ES97402821T patent/ES2157539T3/es not_active Expired - Lifetime
- 1997-11-24 DE DE69704755T patent/DE69704755T2/de not_active Expired - Fee Related
- 1997-11-25 JP JP9321858A patent/JPH10158260A/ja active Pending
- 1997-11-25 US US08/977,793 patent/US5889045A/en not_active Expired - Fee Related
- 1997-11-25 NO NO975402A patent/NO975402L/no not_active Application Discontinuation
- 1997-11-25 BR BR9705064A patent/BR9705064A/pt unknown
- 1997-11-25 CA CA002222467A patent/CA2222467C/fr not_active Expired - Fee Related
- 1997-11-25 CN CN97122919A patent/CN1183412A/zh active Pending
- 1997-11-25 HU HU9702227A patent/HUP9702227A3/hu unknown
- 1997-11-26 AU AU45383/97A patent/AU720479B2/en not_active Ceased
- 1997-11-26 ZA ZA9710649A patent/ZA9710649B/xx unknown
- 1997-11-26 PL PL97323339A patent/PL323339A1/xx unknown
- 1997-11-26 NZ NZ329264A patent/NZ329264A/en unknown
-
2001
- 2001-07-19 GR GR20010401091T patent/GR3036242T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE69704755T2 (de) | 2002-02-28 |
FR2756284B1 (fr) | 2000-04-28 |
PT844245E (pt) | 2001-09-28 |
CN1183412A (zh) | 1998-06-03 |
DE69704755D1 (de) | 2001-06-13 |
JPH10158260A (ja) | 1998-06-16 |
DK0844245T3 (da) | 2001-06-11 |
HUP9702227A2 (hu) | 1998-12-28 |
US5889045A (en) | 1999-03-30 |
NO975402D0 (no) | 1997-11-25 |
NO975402L (no) | 1998-05-27 |
EP0844245A1 (fr) | 1998-05-27 |
NZ329264A (en) | 1998-04-27 |
AU720479B2 (en) | 2000-06-01 |
ZA9710649B (en) | 1998-06-12 |
AU4538397A (en) | 1998-05-28 |
PL323339A1 (en) | 1998-06-08 |
HU9702227D0 (en) | 1998-01-28 |
CA2222467A1 (fr) | 1998-05-26 |
BR9705064A (pt) | 1999-07-20 |
ATE201020T1 (de) | 2001-05-15 |
HUP9702227A3 (en) | 1999-03-01 |
FR2756284A1 (fr) | 1998-05-29 |
GR3036242T3 (en) | 2001-10-31 |
CA2222467C (fr) | 2002-05-28 |
EP0844245B1 (fr) | 2001-05-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO913384L (no) | Fremgangsmaate for fremstilling av serotonin 5ht1a-agonister. | |
BR9803295A (pt) | preparos e composições farmacêuticas contendo os mesmos. | |
ES2081187T3 (es) | Nuevas naftil-alquil-aminas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen. | |
NO302366B1 (no) | 4-merkaptoacetylamino-£2|benzazepinon(3)-derivater, og farmasöytisk preparat | |
ES2195121T3 (es) | Uso de una sal farmaceuticamente aceptable de (3r,2'r)-3-((ciclopentilhidroxifenilacetil)oxi)-1,1-dimetilpirrolidinio para la preparacion de un medicamento. | |
MX9300786A (es) | Compuestos hipolipidaemicos. | |
ES2159922T3 (es) | Nuevos derivados de bencimidazol, de benzoxazol y de benzotiazol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
PA8568501A1 (es) | Compuestos oxo-azabiciclicos | |
ES2118203T3 (es) | Nuevos derivados benzopiranicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
ES2157539T3 (es) | Derivados del benzopirano, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
ES2062706T3 (es) | Nuevos derivados de amino-metil-piperidina su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
ES2162404T3 (es) | Nuevos derivados del indol y del indazol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
ES2069281T3 (es) | Derivado de fenantreno. | |
DK0736029T3 (da) | Antikonvulsive pseudofructopyranosesulfamater | |
ES2183492T3 (es) | Nuevos derivados de nitrono,su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
ES2032752T3 (es) | Procedimiento de preparacion de derivados de la 1-bencenosulfonil-2-oxo-5-alcoxi-pirrolidina. | |
ES2172023T3 (es) | Nuevos derivados tetrahidro-piridinicos sustituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
ES2111871T3 (es) | Nuevos derivados de aminoacidos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
ES2160308T3 (es) | Nuevos derivados amino-metil-heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
MX9301235A (es) | DERIVADOS 1,4-DIOXINO(2,3-B)PIRIDINA. á | |
ES2157541T3 (es) | Derivados de n-bencil-piperazina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
ES2077473T3 (es) | Nuevos compuestos tiocromanicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
ES2182090T3 (es) | Nuevos derivados de pirrol. | |
ES2094324T3 (es) | Nuevos derivados de pirrolidina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
ES2178718T3 (es) | Nuevos derivados de pirazoles acidos, su procedimiento de preparaacion, su aplicacion como medicamentos, su nueva utilizacion y composicion farmaceuticas que los contienen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 844245 Country of ref document: ES |